CoChat

Anxiogenic properties of an inverse agonist selective for α 3 subunit‐containing GABAA receptors

Open access
Atack, John R, Hutson, Peter H, Collinson, Neil, Marshall, George, Bentley, Graham, Moyes, Christopher, Cook, Susan M, Collins, Ian, Wafford, Keith, McKernan, Ruth M, Dawson, Gerard R · 2005 · British Journal of Pharmacology
Cited by 134

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

α 3IA (6‐(4‐pyridyl)‐5‐(4‐methoxyphenyl)‐3‐carbomethoxy‐1‐methyl‐1 H‐pyridin‐2‐one) is a pyridone with higher binding and functional affinity and greater inverse agonist efficacy for GABA A receptors containing an α 3 rather than an α 1, α 2 or α 5 subunit. If doses are selected that minimise the occupancy at these latter subtypes, then the in vivo effects of α 3IA are most probably mediated by the α 3 subtype. α 3IA has good CNS penetration in rats and mice as measured using a [3 H]Ro 15‐1788 in vivo binding assay. At doses in rats that produce relatively low levels of occupancy (12%) in the cerebellum (i.e. α 1‐containing receptors), α 3IA (30 mg kg−1 i.p.), like the nonselective partial inverse agonist N‐methyl‐β‐carboline‐3‐carboxamide (FG 7142), not only caused behavioural disruption in an operant, chain‐pulling assay but was also anxiogenic in the elevated plus maze, an anxiogenic‐like effect that could be blocked with the benzodiazepine antagonist Ro 15‐1788 (flumazenil). Neurochemically, α 3IA (30 mg kg−1 i.p.) as well as FG 7142 (15 mg kg−1 i.p.) increased the concentration of the dopamine metabolite 3,4‐dihydroxyphenylacetic acid in rat medial prefrontal cortex by 74 and 68%, respectively, relative to vehicle‐treated animals, a response that mimicked that seen following immobilisation stress. Taken together, these data demonstrate that an inverse agonist selective for GABA A receptors containing an α 3 subunit is anxiogenic, and suggest that since α 3‐containing GABA A receptors play a role in anxiety, then agonists selective for this subtype should be anxiolytic. British Journal of Pharmacology (2005) 144, 357–366. doi:10.1038/sj.bjp.0706056

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706056

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 134

Metadata

Authors
Atack, J. R., Hutson, P. H., Collinson, N., Marshall, G., Bentley, G., Moyes, C., Cook, S. M., Collins, I., Wafford, K., McKernan, R. M., & Dawson, G. R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2005-02
Volume
144
Issue
3
Pages
357-366
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2090116461
Cited by
134
References
7
FWCI
5.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anxiogenic properties of an inverse agonist selective for α 3 subunit‐containing GABAA receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0706056
The paper
Atack, J. R., Hutson, P. H., Collinson, N., Marshall, G., Bentley, G., Moyes, C., Cook, S. M., Collins, I., Wafford, K., McKernan, R. M., & Dawson, G. R. (2005). Anxiogenic properties of an inverse agonist selective for α 3 subunit‐containing GABAA receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.